Revenue doubles YoY to ₹627 Cr; TruAlt Q1 PAT jumps to ₹59 Cr from near-breakeven
PAT +1154.4% YoY · revenue +106.3% · margins expanding
₹626.88 Cr
+106.3% YoY
₹59.27 Cr
+1154.4% YoY
9.24%
+7.8pp YoY
₹6.67
TruAlt Bioenergy's Q1 FY27 consolidated revenue more than doubled year-on-year to ₹626.88 Cr, up 106% from ₹303.89 Cr in the year-ago quarter and 5.3% sequentially over ₹595.52 Cr. Consolidated PAT swung to ₹59.27 Cr from just ₹4.73 Cr a year earlier — the June-2025 quarter was near-breakeven (PBT of only ₹5.80 Cr), depressed by the ethanol tender-allocation issues that dogged FY26 — so the leap reflects a genuine recovery in ethanol offtake rather than a purely optical low base. EPS came in at ₹6.67; standalone revenue was ₹615.92 Cr with PAT of ₹55.01 Cr (EPS ₹6.41).
Q1 FY-2027 vs prior quarters
The print was carried almost entirely by the Ethanol & other products segment, which delivered ₹615.68 Cr of revenue and a ₹225.84 Cr segment result; the nascent Compressed Biogas segment added ₹11.21 Cr revenue and ₹9.24 Cr result. Operating margin expanded to roughly 21% (from 13.7% YoY) and net margin to ~9.5% (from 1.5% YoY) on the higher ethanol volumes and mix. There were no exceptional items on either side, and the ₹19.17 Cr tax line was almost wholly deferred. Sequentially, against a seasonally strong March quarter, revenue rose modestly and profitability held broadly steady — ethanol/sugar-linked businesses are seasonal, so the year-on-year comparison is the cleaner read.
The stock went into the print at ₹419.15, down 8.8% over the past month of trading.
What the summary numbers don't show
No exceptional items — ₹19.17 Cr tax charge almost entirely deferred; profit-for-period includes ₹2.12 Cr non-controlling interest
Management projects continued revenue growth driven by increased ethanol allocation (targeting 55 crore liters, including pending court order implementation), expansion in Compressed Biogas (CBG) plants to 162 tons per day by FY27, and the development of Sustainable Aviation Fuel (SAF) and fuel retail outlets. While FY
— This quarter: met
The result squares with management's May concall guidance of a recovery driven by higher ethanol allocation (targeting 55 crore litres, including a pending court-order implementation), CBG expansion to 162 tpd by FY27, and diversification into SAF and fuel retail — the doubling of revenue is consistent with that recovery, though CBG remains tiny for now. During the quarter TruAlt secured ₹150 Cr under the PM JI-VAN Yojana for its SAF project. There is no formal quarterly numeric guidance and no published brokerage consensus for this recently listed name; a Smartkarma note had framed FY27 as the company's 'payoff' year. The auditor issued an unmodified limited review, with an emphasis of matter on the still-pending Unit-4 componentisation (mono-to-dual feed, capitalised February 2026).
W1
Ethanol allocation ramp toward the 55-crore-litre target (incl. pending court order) — Q1's ₹626.88 Cr implies a ~₹2,500 Cr annualised run-rate to sustain
W2
CBG scale-up to 162 tpd by FY27 — segment still only ₹11.21 Cr revenue this quarter
W3
SAF project progress on the ₹150 Cr PM JI-VAN funding, plus Unit-4 componentisation completion and its depreciation impact
Clean digital PDF, in ₹ lakhs. Consolidated PAT ₹59.27 Cr is profit-for-period incl. NCI ₹2.12 Cr (parent ₹57.15 Cr). No exceptional items either period; tax charge almost entirely deferred. Board letter calls results 'audited' but statement columns are labelled 'Unaudited' with an unmodified limited review — treated as unaudited/limited-review. Emphasis of matter: Unit-4 mono-to-dual-feed componentisation (capitalised Feb 2026) pending. Our DB's prior-quarter PAT (₹60.95 Cr) differs from the filing's own March column (₹68.84 Cr); QoQ computed on the DB record.
Dual-Feed Payoff Is Real, but Q2 Will Strip Away the Windfall
Headline numbers soar (106% revenue, 1154% profit YoY), but Q1 saw PAT fall 2.8% QoQ despite higher volumes. The maize inventory benefit inflates margins by ₹9–10 per liter—a non-recurring tailwind that ends next quarter.
₹59.3 Cr
+1,154% YoY, -2.8% QoQ
~₹9–10/liter
Maize ₹18-22 vs. spot ₹25.50
~₹10–12
vs. ₹15–16 on lock-in
The tension: Headline growth masks margin compression
TruAlt reported a blowout: ₹626.9 Cr revenue (+106% YoY), ₹59.3 Cr PAT (+1,154% YoY). The day-1 market reaction was +2.62% delivery. On a 52-week chart, the pop held—day 5 still up +4.19%. But the call reveals the real story. Despite Q1 revenues rising 5.3% QoQ, PAT fell 2.8%. That gap—growth without leverage—tells you margin pressure is already here.
The culprit is inventory. TruAlt booked maize at ₹18–₹22 per kg when it was cheaper. That stock is now valued against a spot price of ₹25.50/kg—a ₹9–₹10 per liter margin benefit that is non-recurring. Once the dual-feed plants cycle through that inventory (expected Q2), normalized maize cost yields only ₹6–₹7 per liter margin, versus the ₹15–₹16 the quarter is banking on. Employee cost additions (180 CBG hires) and a ₹11 Cr finance drag absorbed the volume uplift.
Revenue close to ₹630 Cr, ethanol 8.5 Cr liters produced
₹626.9 Cr revenue, 8.5 Cr liter sales guidance matched
Supported
44 Cr liters orders on hand for FY27
44 Cr liters confirmed; 55 Cr capacity target implied 80% conversion, not a miss
Supported (but partial guidance)
Grain-based feedstock 6% margin better than sugar
Confirmed: grain ₹314 Cr vs. sugar ₹277 Cr on similar volume; 50:50 blend this Q
Supported
CBG 40–50% PAT margin at 78% utilization
CBG ₹11.2 Cr revenue, ₹5.1 Cr PBT = 45.5% margin; 1x maintenance cost cited
Supported
15 Cr liter court case implementation imminent
MD: 'still stands open, making all efforts' but no timeline disclosed
Unresolved—not in base 44 Cr guidance
What changed on this call
Dual-feed transition complete: 3 of 5 plants on grain blend; 6% margin lift realized
CBG capex accelerated: 132 TPD new capacity by Q4 FY27 (vs. FY28 prior), ₹760 Cr gross, 70:30 debt
Maize cost trajectory deteriorated: ₹25.50/kg spot vs. ₹22–24 normalized; Q2 headwind ₹9–10/liter
Fuel retail expansion stalled: 76 outlets identified, 7 live, 4 in pipeline; deferred due to Middle East crude volatility
Guidance maintained (55 Cr liters ethanol, CBG, SAF capex), not raised; implicit 44 Cr order base vs. capacity target
The bull-bear ledger
Dual-feed economics proven: grain margin 6% better than sugar; yield 450 vs. 317; co-product DDGS ₹47 Cr upside
CBG pilot validated: 45.5% PAT margin, 78% utilization; JV capex accelerated to Q4 revenue start
44 Cr liters orders provide visibility; OMC + private + ENA channels diversified
Reported PAT soared (+1,154% YoY) but Q1 QoQ fell 2.8% despite 5.3% revenue growth—no leverage materializing
Inventory margin benefit ₹9–10/liter non-recurring; normalized maize ₹6–7/liter hits Q2
Only 44 Cr liters (80% capacity) vs. 55 Cr target; 15 Cr liter court case unresolved—tender allocation risk
Finance cost ₹44 Cr annualized (₹11 Cr this Q) = 7% of revenue; de-leverage plan pending, not disclosed
CBG policy in flux: MDA (fertilizer subsidy) dependence for FOM monetization; Sampoorna program rollout uncertain
SAF adoption uncertain: ₹2,000 Cr capex, FY29 revenue, ₹180–200/liter price = 1.8x ATF; airline cost sensitivity high
Risks, ranked by how much they should concern a holder
Inventory margin windfall fades Q2
HighMaize ₹18–22 lock-in realizing ₹15–16/liter margin; spot ₹25.50 yields ₹6–7/liter. Q2 procurement headwind ₹9–10/liter. Strip away the benefit and adjusted EBITDA margin falls to 16–18% from Q1's 23.5%.
Tender allocation fairness (44 Cr vs. 55 Cr capacity)
HighOnly 80% utilization on filed capacity. MD flagged 'unfair means' in prior allocation. Sept–Oct new ethanol bidding cycle critical. If 44 Cr holds, FY27 revenue tops out ~₹3,000 Cr (vs. ₹3,700 Cr at full capacity).
Maize cost volatility
HighAt ₹22–24/kg (normalized), margins ₹10–12/liter; locked-in benefit ₹9–10/liter masks Q2 pressure. Spot ₹25.50 already compresses to ₹6–7/liter. Policy change or global supply shock could extend the pain.
Finance cost burden
Medium-High₹44 Cr annualized (₹11 Cr Q1) on ₹626.9 Cr revenue = 7% drag. DSCR 1.36x leaves little margin for rate shocks. De-leverage plan exists but not disclosed. At current leverage, FCF available for capex or buyback is constrained.
CBG policy flux (MDA subsidy, Sampoorna rollout)
MediumCBG 40–50% PAT margins dependent on FOM monetization at ₹2,500–2,800/ton. MDA (fertilizer subsidy) under review; Sampoorna program coming with 'multiple corrections.' If subsidy cut, FOM realization falls, margin to 25–35% PBT. JV capex (₹760 Cr) is at risk if returns fall.
15 Cr liter court case unresolved
MediumNot in base 44 Cr guidance. If it resolves, adds ~₹1,000 Cr incremental FY27 revenue and materially raises PAT. If it doesn't, upside story breaks. No timeline disclosed.
SAF adoption and pricing uncertainty
Medium₹2,000 Cr capex for FY29 revenue is contingent on airline willingness to pay ₹180–200/liter (1.8x ATF). Carbon benefit alone may not drive adoption without mandates. EPC bidding in 2–3 months; execution risk high.
How the street is positioned
Post-result price action confirms the market believes the story, for now. The day-1 pop of +2.62% (from ₹419.15 pre-result) held—by day 5 the stock was up +4.19%. That tells you institutional buyers saw the dual-feed transition and CBG acceleration as credible, not a one-quarter fluke. Volume was normal, not climactic.
But valuation and positioning show cracks. The stock is at ₹481.6, -11.14% from its all-time high of ₹542. It's trading above its SMA20 (₹446.52), SMA50 (₹460.83), and SMA200 (₹433.48)—a classic uptrend. Yet RSI is 72.4 (overbought), and momentum could fade if Q2 earnings quality deteriorates.
Institutional flows are trimming, not adding. FII ownership fell 0.08 percentage points QoQ (0.58% now vs. 0.66% prior); DII fell 1.04pp (8.36% now vs. 9.40% prior). That's not a rout, but it's not conviction buying either. The June bulk deals show retail/prop activity (₹516–₹506/share range), but no promoter insider buying at these levels—a yellow flag.
The market's verdict is cautiously bullish on the decade-long structural story (ethanol blending, CBG policy tailwinds, SAF early-mover edge) but wary of the next quarter's earnings quality. That's a reasonable read.
The debate
What to watch next
1 · Q2 FY27 sales and EBITDA margin (next quarter)
Management guided 11–12 Cr liter sales. The acid test: does EBITDA margin hold above 20% without the inventory windfall, or does it compress to 16–18%? Maize cost trajectory (is it stabilizing or staying elevated at ₹25+/kg?) will answer this. If normalized, adjusted EBITDA margin validates the dual-feed thesis at ₹10–12/liter. If not, the bear case wins.
2 · CBG JV first revenues (Q4 FY27, Sep–Dec 2026)
3 Sumitomo plants + 6 GAIL plants (132 TPD total, 51% TruAlt ownership) expected to generate revenue by Q4. Key metrics: utilization (60% Y1 assumed), FOM realization (₹2,500–2,800/ton current, ₹6,000 target), gas pricing (₹84/kg static). If CBG PAT margin falls below 40% at 70%+ utilization, policy risk (MDA/Sampoorna) is real and de-rates capex returns.
3 · Tender allocation fairness (Sept–Oct 2026, next bidding cycle)
The new ethanol allocation cycle will tell you if 44 Cr liters was a low-ball due to 'unfair means' or a structural ceiling. If TruAlt secures 50+ Cr liters, the court case upside becomes less critical. If it stays at 44 Cr (or lower), tender allocation risk is embedded and FY27 revenue tops out ~₹3,000 Cr.
4 · 15 Cr liter court case resolution (timing TBD)
If implemented, adds ~₹1,000 Cr revenue upside (at ₹67/liter). PAT upside ₹100–150 Cr (at 12–15% margin). This is optionality, not base case. No timeline, so price it at <50% probability. Resolution or closure would materially de-risk the guidance and validate the bull case.
5 · De-leverage plan disclosure
MD dodged this on the call. Finance cost ₹44 Cr annualized is high relative to EBITDA ₹147 Cr (30% of EBITDA). If management commits to de-leverage (refinancing, asset sales, equity raise), it signals confidence in cash generation. Absence of a plan by Q2 call is a negative signal.
6 · SAF capex progress (next 2–3 months, FEED completion)
EPC bidding underway. Land procurement from Andhra Pradesh state. If execution slips (common on ₹2,000 Cr capex), FY29 revenue timeline at risk. Early wins (binding MOUs with airlines, finalized capex budget) would de-risk the story.
The verdict
Credibility grade: B. Management hit Q1 revenue and PAT targets disclosed in the CFO deck (₹625+ Cr, ₹59+ Cr). Guided 55 Cr liters ethanol capacity and CBG, SAF expansion timelines have not moved. Shortfall: 44 Cr liters orders (80% of capacity target) vs. 55 Cr full-year run-rate; 15 Cr liter court case remains unresolved with no formal timeline; Q1 QoQ PAT compression despite revenue growth signals margins softer than expected. Not a trust breach, but a reminder that the next two quarters are execution tests, not confirmation rallies.
TruAlt's dual-feed transition is real, and the economics (6% margin lift on grain vs. sugar) are proven. CBG capex and SAF ambitions are credible for a mid-sized biofuels player with government backing. But Q1's reported profit is inflated by an inventory benefit that fades in Q2. Tender allocation to 80% of capacity (44 Cr vs. 55 Cr liters) and unresolved court case add risk. The honest read is steady, disciplined capital deployment, not a breakout. Finance cost (₹44 Cr annualized) is material and unsustainable without de-leverage. The market's post-result rally (+4.19% by day 5) was justified but is now overbought (RSI 72.4). Conviction lies in Q2 earnings quality: if normalized maize cost (₹22–24/kg) and tender allocation dynamics hold firm, adjusted EBITDA margin (ex-inventory benefit) will stabilize around 18–20%, validating the dual-feed case. If not, downside to ₹420–440 is likely. The number to track is adjusted EBITDA margin per liter—it's the true measure of earnings power.
Dual-feed payoff drives 106% YoY growth; macro headwinds cap upside
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Hit Q1 revenue and PAT targets; maintained prior guidance (55 Cr liters, CBG, SAF). Shortfall: court case remains open; Q1 QoQ margin softness vs expectations.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong delivered Q1 (₹627 Cr revenue, +106% YoY) on dual-feed transition and capacity ramp. But Q1 QoQ PAT fell 2.8% despite higher volumes—employee costs and finance drag offset revenue gains. Guidance maintained (55 Cr liters, CBG, SAF) but not raised; 15 Cr liter court case and policy uncertainties (CBG subsidy, SAF adoption) cap upside. Best case: 44 Cr liters FY27 + CBG Q4 start = mid-teen PAT growth. Risk: maize at ₹25.50 eats ₹9-10/liter margin vs locked-in stocks; tender fairness flagged.
₹626.9 Cr
Revenue · +106.3% YoY₹59.3 Cr
Reported PAT · +1154.4% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue close to ₹630 Cr, ethanol 8.5 Cr liters produced
MET₹626.9 Cr revenue, consistent with 8.5 Cr liter sales guidance
PAT ₹59.3 Cr, YoY growth >1,000%
MET₹59.3 Cr PAT, YoY 1154.4%; QoQ -2.8% despite higher volumes
EBITDA margin 23.5%, PAT margin 9.5%
METEBITDA ₹147.3 Cr (23.5%), PAT ₹59.3 Cr (9.45%); OPM 21.2% reported (slight variance)
44 Cr liters orders on hand for FY27
METFull-year ethanol target 55 Cr liters; 44 Cr viability imply 80% conversion assumption, not a miss
Grain-based feedstock 6% margin better than sugar-based
METConfirmed: CFO stated grain margin 6% higher; 50:50 blend this Q, targeting more grain next Q
CBG 40-45% PAT margin at 78% utilization
METCBG ₹11.2 Cr revenue, ₹5.1 Cr PBT = 45.5% margin; caveat: 1x maintenance cost cited
Q2 FY27 should see healthy numbers with 11-12 Cr liter orders
PartialNo quantified PAT guidance; orders on hand confirmed but price/mix TBD
15 Cr liters court case still pending implementation
METMD: 'still stands open, making all efforts' but no timeline. Not included in base 44 Cr guidance.
Earnings quality
What changed since the last call
Dual-feed plant integration
Upgrade3 of 5 plants converted by Q1; grain feedstock yield 450 vs 317 sugar, 6% margin lift demonstrated
Ethanol tender allocation
Neutral44 Cr liters orders vs 55 Cr capacity target; management cites 'unfair means' but no formal guidance miss
CBG capex acceleration
Upgrade10 new plants (132 TPD) via JVs (Sumitomo 51%, GAIL 51%, ₹760 Cr gross). Q4 revenue start vs prior Q1 FY28 expectation
Maize cost trajectory
DowngradeLocked-in at ₹18-22/kg giving ₹15-16/liter margin; spot now ₹25.50 yields ₹6-7/liter. Q2 headwind unless replenished at lower cost
Fuel retail expansion
Downgrade7 outlets operating, 4 in pipeline for Q1 close. 76 identified but stalled due to Middle Eastern crisis crude volatility
The Q&A
Analysts pressed on CBG margin sustainability (Q1 dip), SAF pricing (1.8x ATF), court case timeline (none), and macro headwinds. Management held ground on ₹40-50% CBG PAT margins as long-term baseline, deflected SAF adoption uncertainty but defended carbon offset value. Tone defensive on policy dependence; confident on volumes.
Dual-feed feedstock mix — Shubhi Gupta, Trinetra Asset Managers
AnsweredGrain margin 6% better than sugar. Grain yield 450 vs sugar 317. This Q 50:50 blend, targeting more grain next Q. DDGS co-product adds income.
CBG margin dip — Shubhi Gupta, Trinetra Asset Managers
AnsweredEmployee cost increase for JV expansions (Sumitomo, GAIL hiring). 1x R&M cost. Minor impact, Q1 FY25 was similar. Nothing structural.
Asset turn and capex plans — Shilpa, Lotus Wealth
AnsweredAt 55 Cr liter capacity + ₹67 price = ₹4,000 Cr, asset turn 1.8-2x. Ethanol capex done; CBG ₹700 Cr underway, SAF ₹2,000 Cr planned next 2-3 months.
Ethanol volume split and maize outlook — Sanjay Manyal, DAM Capital
AnsweredSugar 4.37 Cr liters (₹277 Cr), grain 3.92 Cr liters (₹314 Cr). B-molasses 3.35 Cr. Maize ₹18-22 booked = ₹15-16/liter; current ₹25.50 = ₹6-7/liter. At ₹22-24 normal, margins ₹10-12/liter.
15 Cr litre court case status — Tanmay Jhaveri, Finterest Capital
Partial44 Cr liters does not include 15 Cr spillover. Still fighting with OMCs. No timeline, making all efforts. Hopeful it comes through anytime.
SAF collaborations and pricing — Tanmay Jhaveri, Finterest Capital
Answered6 companies discussed (aircraft OEM, 2 airlines, 3 oil/gas players). Sumitomo MOU in place. SAF price ₹180-200/liter, margin 24-25%. Expectation cost < international ATF due to scale.
CBG raw material and offtake — Satyam Chaudhary, Individual Investor
AnsweredAll locations in clusters of sugar/ethanol plants. 3x raw material (press mud, spent wash) within 30 km radius. GAIL partner ensures 80-90% offtake daily.
CBG byproduct (FOM) monetization — Suyash Kela, Singularity AMC
PartialSolid FOM was ₹500/ton, now ₹2,500-2,800. In talks with Coromandel at ₹6,000/ton. Long-term offtake with IFFCO, MCF. Liquid FOM needs market dev. Pursuing policy support but aiming for less dependence.
Ethanol demand-supply — Arijit Malalkar, Ashika Stock Services
AnsweredIndia capacity 1,800 Cr liters. Demand: 1,200 (blending), 300 (chemicals), 200 (AlcoBev). At 20% blend, supply-demand par. Sugar companies lack our dual-feed flexibility, biomass boilers, group raw material backup.
Private OMC realization and inventory — Vineet Thakur, Plus91 AMC
AnsweredPrivate OMCs at ₹60.50 vs ₹67-68 government. 8 Cr liters inventory: 3 Cr sold, 5 Cr to be sold by Q3 FY27. Challenging margins with RON 95 mandate.
Balance sheet de-leveraging — Parth Shah, Individual Investor
DodgedPlans in works, will share next call or in few days. Not committed to fundraising; working on de-leverage strategy internally.
Guidance
FY27: 44 Cr liter ethanol orders on hand
HighConfirmed by MD in Q&A; includes OMC + private + ENA. At ₹67-68/liter = ₹2,950-2,990 Cr ethanol revenue potential.
Q2 FY27: 11-12 Cr liter sales planned
MediumOrders in hand, but price and product mix (grain vs sugar) TBD. At current margins ₹10-15/liter = ₹110-180 Cr EBITDA potential.
CBG Q4 FY27 revenue start from JV plants
Medium3 Sumitomo plants near commissioning, 6 GAIL locations in land acquisition. 51% ownership, 132 TPD total, ₹4.5 Cr/ton revenue at peak.
Ethanol EBITDA margin: 20-25% at 55 Cr capacity utilization
MediumQ1 achieved 23.5% aided by inventory drawdown. Normalized grain margin ₹10-12/liter (vs ₹6-7 spot maize). Sensitivity to feedstock cost high.
CBG PAT margin: 40-50% long-term (post 1x costs)
MediumQ1 achieved 45.5% at 78% utilization. Dependent on gas pricing (₹84/kg static) and FOM monetization (upside to ₹6,000/ton if deals close).
SAF margin: 24-25% at planned utilization
LowPrice ₹180-200/liter expected, cost structure TBD. Airlines pricing pressure and policy subsidy (viability gap ₹150 Cr) create risk.
CBG: ₹700-760 Cr gross for 10 new plants (132 TPD), 70:30 debt, 51% ownership
HighSumitomo ₹330 Cr, GAIL ₹425 Cr. Q4 FY27 revenue start from first 9 plants. Land & construction underway.
SAF: ₹2,000 Cr capex, FY29 revenue start
MediumFEED phase ongoing. EPC bidding in next 2-3 months. Land procurement from Andhra Pradesh. ₹150 Cr viability gap funding secured.
Ethanol capex: None planned; fully commissioned dual-feed integration complete
HighQ3 FY26 integration finished. Capacity 2,000 KLPD (55 Cr liters annualized) requires only OpEx from here.
Risks the call surfaced
Tender allocation risk
High44 Cr liters orders (80% of 55 Cr capacity) vs full capacity. MD flagged 'unfair means' in prior allocation. Sept-Oct new ethanol cycle critical; uncertainty remains.
Raw material cost volatility
HighMaize locked-in at ₹18-22/kg yields ₹15-16/liter margin; spot now ₹25.50 yields ₹6-7/liter. Q2 procurement at higher cost will compress margins unless feedstock mix shifts to lower-cost sugar.
CBG policy and subsidy dependence
MediumCBG 40-50% PAT margins partly dependent on government MDA (fertilizer subsidy) for FOM byproduct. Sampoorna program coming; policy changes could reduce FOM realization and compress margins below 40%.
CBG partner execution risk
Medium10 new CBG plants (132 TPD) via Sumitomo (51%) and GAIL (51%) JVs. MD assumes 60% Y1 utilization for new plants. GAIL offtake guaranteed 80-90%, but Sumitomo plant ramp-up and capital control 49% partner.
SAF adoption and pricing risk
MediumSAF price target ₹180-200/liter is 1.8x current subsidized ATF (₹125-130). Airlines cost-conscious; margin 24-25% assumes full capacity use. Carbon benefit alone may not drive adoption without government mandates; deployment to FY29 exposes to policy/market changes.
Finance cost burden
MediumFinance cost ₹44 Cr annualized (₹11 Cr this Q) on ₹626.9 Cr quarterly revenue. Debt-equity 0.59x reasonable, but DSCR 1.36x leaves little margin for refinancing or rate shocks. De-leverage plan in works but not committed.
Management
Score 7/10. Direct, number-heavy Q&A with clear volume/price breakups. Transparent on headwinds (court case, tender fairness, maize cost, policy flux). Evasive on de-leverage timeline and advertising delays; not defensive but non-committal. Delivered Q1 revenue and PAT targets (₹627 Cr, ₹59 Cr). Maintained prior guidance (55 Cr liters, CBG, SAF) but implicit 80% conversion (44 Cr vs 55 Cr orders). Dual-feed transition completed on time. CBG JV capex underway. SAF still in FEED phase (EPC bidding in 2-3 months).
1 · Q2 FY27
11-12 Cr liter sales guidance; test of demand & maize cost impact
2 · Q4 FY27 (Sep-Dec 2026)
CBG JV first revenue: 3 Sumitomo plants + 6 GAIL plants (132 TPD), 60% Y1 utilization assumed
3 · Court case (timing TBD)
15 Cr liter allocation if implemented = ₹1,000+ Cr incremental revenue upside
Risk: maize at ₹25.50 eats ₹9-10/liter margin vs locked-in stocks; tender fairness flagged.